Clinical Trial Update: Latiglutenase as a Treatment for Celiac Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for latiglutenase as a treatment for celiac disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• Latiglutenase (latiglutenase)

Snippet

Sponsor: Immunogenics, LLC | Conditions: Celiac Disease | Phase 2 | Status: COMPLETED